These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27484193)

  • 1. Endocannabinoid system: Role in depression, reward and pain control (Review).
    Huang WJ; Chen WW; Zhang X
    Mol Med Rep; 2016 Oct; 14(4):2899-903. PubMed ID: 27484193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.
    Fitzgibbon M; Finn DP; Roche M
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv095. PubMed ID: 26342110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
    Hu SS; Ho YC; Chiou LC
    Eur J Neurosci; 2014 Feb; 39(3):467-84. PubMed ID: 24494686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The endocannabinoid system role in the pathogenesis of obesity and depression].
    Zdanowicz A; Kaźmierczak W; Wierzbiński P
    Pol Merkur Lekarski; 2015 Jul; 39(229):61-6. PubMed ID: 26277182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids in depressive disorders.
    Poleszak E; Wośko S; Sławińska K; Szopa A; Wróbel A; Serefko A
    Life Sci; 2018 Nov; 213():18-24. PubMed ID: 30290188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control.
    Piscitelli F; Di Marzo V
    ACS Chem Neurosci; 2012 May; 3(5):356-63. PubMed ID: 22860203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids in pain modulation.
    Walker JM; Huang SM
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):235-42. PubMed ID: 12052039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs--A practical view.
    Fowler CJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):749-62. PubMed ID: 25791296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
    Di Marzo V
    Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabinoids in the control of pain].
    Shaladi AM; Crestani F; Tartari S; Piva B
    Recenti Prog Med; 2008 Dec; 99(12):616-24. PubMed ID: 19388223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.